Target intelligence / Profile preview

23S ribosomal RNA–ribosomal protein uL11–elongation factor G translocation site (SRL–uL11–EF-G site)

Target
SRL–uL11–EF-G site
Molecular classification
Ribosomal RNA, Ribosomal protein, Translation elongation factor, GTPase, Ribosome functional site
01

Overview

The SRL–uL11–EF-G site in prokaryotic ribosomes is the functional center for GTP hydrolysis and translocation during protein synthesis. 23S rRNA forms the core of the large subunit and contains the sarcin-ricin loop, which interacts with the GTPase domain of EF-G, a translation factor responsible for catalyzing mRNA and tRNA movement across the ribosome after each peptide bond is formed. Ribosomal protein uL11, together with adjacent rRNA sequences, helps organize the L11 stalk, facilitating interactions with EF-G and other translational GTPases. The precise arrangement and dynamic interactions of these components are essential for the rapid and accurate translocation of substrates needed for protein synthesis, and they represent major targets for antibiotics such as fusidic acid, which inhibits translocation by preventing EF-G dissociation after GTP hydrolysis.

Other names
Sarcin-ricin loop–L11 stalk–EF-G complexGTPase activation center (in the ribosome)
02

Mechanism of action

Antibiotic binding blocks conformational changes essential for EF-G-mediated translocation and/or GTP hydrolysis, stalling protein synthesis

03

Biological functions

Protein translation/elongationGTP hydrolysistRNA and mRNA translocation
04

Disease associations

InfectionAntibiotic resistance
05

Safety considerations

Specific to antibacterial use (not applicable to humans; disruption causes toxicity to bacteria only)Resistance mutations in ribosomal RNA or EF-G may reduce antibiotic efficacy
06

Interacting drugs

Fusidic acid

2 more in the full profile.

Beyond the preview

Go deeper on 23S ribosomal RNA–ribosomal protein uL11–elongation factor G translocation site (SRL–uL11–EF-G site).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 23S ribosomal RNA–ribosomal protein uL11–elongation factor G translocation site (SRL–uL11–EF-G site).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call